Vicarious Surgical Inc. (RBOT) |
|
2.205 0.105 (5%)
|
06-06 15:59 |
|
Open: |
2.1 |
Pre. Close: |
2.1 |
|
High:
|
2.315 |
Low:
|
2.08 |
|
Volume:
|
242,527 |
Market Cap:
|
280(M) |
|
|
|
Technical analysis |
as of: 2023-06-06 3:51:38 PM |
|
Short-term rate:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 2.86 One year: 3.34 |
| Support: |
Support1: 2.09 Support2: 1.87 |
| Resistance: |
Resistance1: 2.45 Resistance2: 2.86 |
| Pivot: |
2.14 |
| Moving Average: |
MA(5): 2.16 MA(20): 2.11
MA(100): 2.43  MA(250): 3.02 |
| MACD: |
MACD(12,26): 0 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 48.7 %D(3): 48.5 |
| RSI: |
RSI(14): 52.5 |
| 52-week: |
High: 4.76 Low: 1.36 |
| Average Vol(K): |
3-Month: 351 (K) 10-Days: 204 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ RBOT ] has closed below upper band by 35.1%. Bollinger Bands are 39.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.25 - 2.27 |
2.27 - 2.28 |
|
Low:
|
2.07 - 2.09 |
2.09 - 2.1 |
|
Close:
|
2.08 - 2.1 |
2.1 - 2.12 |
|
Company Description |
|
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts. |
Headline News |
Fri, 26 May 2023
Insider Sell: CFO and Treasure - GuruFocus.com
Thu, 18 May 2023
Vicarious Surgical Announces Promotion of John Mazzola to Chief ... - Business Wire
Mon, 08 May 2023
Vicarious Surgical Reports First Quarter 2023 Financial Results - Business Wire
Thu, 04 May 2023
Vicarious Surgical Earns Recognition from Fast Company and MedTech Breakthrough Awards - Yahoo Finance
Mon, 24 Apr 2023
Vicarious Surgical to Report First Quarter 2023 Financial Results on ... - Business Wire
Sat, 22 Apr 2023
While institutions invested in Vicarious Surgical Inc. (NYSE:RBOT) benefited from last week's 11% gain, private equity firms stood to gain the most - Simply Wall St
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
107 (M) |
| Shares Float |
53 (M) |
|
% Held by Insiders
|
35.7 (%) |
|
% Held by Institutions
|
40.6 (%) |
|
Shares Short
|
5,220 (K) |
|
Shares Short P.Month
|
5,070 (K) |
Stock Financials |
|
EPS
|
-0.56 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0.68 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
-35 |
|
Return on Equity (ttm)
|
-59.6 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
-0.78 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-65 (M) |
|
Levered Free Cash Flow
|
-41 (M) |
Stock Valuations |
|
PE Ratio
|
-4.02 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
3.2 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
-3.65 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
